Last updated: June 4, 2024
Sponsor: Université de Sherbrooke
Overall Status: Completed
Phase
N/A
Condition
N/ATreatment
Nocebo
Placebo
Clinical Study ID
NCT05161832
2022-4356
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Aged 18 years old or older
Healthy Volunteers
Capable of understanding instructions
Abstain from tobacco and caffeine 2 hours before data collection
Abstain from short-acting analgesics 6 hours before data collection
Exclusion
Exclusion Criteria:
A painful condition or chronic pain
Neurological disorders
Shoulder pathology
Skin diseases
Capsaicin allergy
Raynaud's syndrome
Epilepsy
Intracranial metallic foreign bodies, hearing aids and cochlear implants
Study Design
Total Participants: 24
Treatment Group(s): 2
Primary Treatment: Nocebo
Phase:
Study Start date:
January 15, 2022
Estimated Completion Date:
January 29, 2024
Study Description
Connect with a study center
Centre de Recherche sur le Vieillissement
Sherbrooke, Quebec J1H 4C4
CanadaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.